Literature DB >> 12021517

Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening.

Kunihiro Yamagata1, Hideto Takahashi, Chie Tomida, Yoh Yamagata, Akio Koyama.   

Abstract

AIM: To elucidate prognosis and prevalence of chronic renal diseases among proteinuric and/or hematuric subjects found in mass screening, a long-term follow-up study (6.35 years, range 1.03-14.6 years) was conducted on Japanese working men.
METHODS: A total of 772 subjects selected from 50,501 Japanese men aged 15-62 years were found to have asymptomatic hematuria (n = 404), concomitant hematuria and proteinuria (n = 155), and proteinuria (n = 213) during their annual urine examination and five consecutive urinalyses.
RESULTS: Hematuria patients showed significant improvements in urinary abnormalities as compared with both hematuria/proteinuria and proteinuria patients. Both hematuria/proteinuria patients with normotension and hematuria/proteinuria patients aged under 40 years showed significant improvements. During the follow-up period, 9.5% of the hematuria patients became hematuric/proteinuric. Hematuria/proteinuria patients had the highest risk of developing renal insufficiency. The presence of hypertension at detection of urinary abnormalities did not affect the renal function; however, if proteinuria appeared after the age of 40 years, these patients had a higher risk of developing renal insufficiency. The incidence of IgA nephropathy in the present subjects was as high as 143 cases per 1 million per year.
CONCLUSION: Detailed follow-up and definitive diagnosis of asymptomatic urinary abnormalities may raise the prevalence of IgA nephropathy worldwide. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12021517     DOI: 10.1159/000057602

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  18 in total

1.  Glomerular isolated microscopic hematuria: urinary features and long term follow-up of a selected cohort of patients.

Authors:  Cecilia Bellincioni; Giuseppe Garigali; Giovanni B Fogazzi
Journal:  J Nephrol       Date:  2018-12-10       Impact factor: 3.902

2.  The prevalence of microscopic hematuria in a cohort of women with pelvic organ prolapse.

Authors:  Nirmala Pillalamarri; Dara Shalom; Sharlene Sanidad; Meredith Akerman; Lawrence Lind; Harvey Winkler
Journal:  Int Urogynecol J       Date:  2014-07-01       Impact factor: 2.894

3.  Japanese guidelines of the management of hematuria 2013.

Authors:  Shigeo Horie; Shuichi Ito; Hirokazu Okada; Haruhito Kikuchi; Ichiei Narita; Tsutomu Nishiyama; Tomonori Hasegawa; Hiroshi Mikami; Kunihiro Yamagata; Tomoji Yuno; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2014-10       Impact factor: 2.801

4.  Design and methods of a strategic outcome study for chronic kidney disease: Frontier of Renal Outcome Modifications in Japan.

Authors:  Kunihiro Yamagata; Hirofumi Makino; Tadao Akizawa; Kunitoshi Iseki; Sadayoshi Itoh; Kenjiro Kimura; Daisuke Koya; Ichiei Narita; Tetsuya Mitarai; Masanobu Miyazaki; Yoshiharu Tsubakihara; Tsuyoshi Watanabe; Takashi Wada; Osamu Sakai
Journal:  Clin Exp Nephrol       Date:  2009-12-18       Impact factor: 2.801

5.  Prevalence and risk factors associated with chronic kidney disease in a Uygur adult population from Urumqi.

Authors:  Chen Lu; Hongjuan Zhao; Gang Xu; Hua Yue; Weili Liu; Kaichun Zhu; Xiaocheng Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-11-10

Review 6.  [Microscopic hematuria : Reasonable and risk-adapted diagnostic evaluation].

Authors:  N Löbig; F Wezel; T Martini; B Schröppel; C Bolenz
Journal:  Urologe A       Date:  2017-09       Impact factor: 0.639

7.  Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China.

Authors:  Wei Chen; Weiqing Chen; Hui Wang; Xiuqing Dong; Qinghua Liu; Haiping Mao; Jiaqing Tan; Jianxiong Lin; Feiyu Zhou; Ning Luo; Huijuan He; Richard J Johnson; Shu-Feng Zhou; Xueqing Yu
Journal:  Nephrol Dial Transplant       Date:  2008-10-24       Impact factor: 5.992

8.  Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015.

Authors:  Wassim Kassouf; Armen Aprikian; Peter Black; Girish Kulkarni; Jonathan Izawa; Libni Eapen; Adrian Fairey; Alan So; Scott North; Ricardo Rendon; Srikala S Sridhar; Tarik Alam; Fadi Brimo; Normand Blais; Chris Booth; Joseph Chin; Peter Chung; Darrel Drachenberg; Yves Fradet; Michael Jewett; Ron Moore; Chris Morash; Bobby Shayegan; Geoffrey Gotto; Neil Fleshner; Fred Saad; D Robert Siemens
Journal:  Can Urol Assoc J       Date:  2016-02-08       Impact factor: 1.862

Review 9.  Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Authors:  Kunihiro Yamagata; Kunitoshi Iseki; Kousaku Nitta; Hirokazu Imai; Yasuhiko Iino; Seiichi Matsuo; Hirofumi Makino; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

10.  Natural history and renal pathology in patients with isolated microscopic hematuria.

Authors:  Byung Soo Kim; Yong Kyun Kim; Young Shin Shin; Young Ok Kim; Ho Cheol Song; Yong Soo Kim; Euy Jin Choi
Journal:  Korean J Intern Med       Date:  2009-11-27       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.